Genomes from 240 mammalian species revealed what makes the human genome unique
On Apr. 27, 2023, Zoonomia scientists announced they have have been cataloging the diversity in mammalian genomes by…
-
-
Biotechnology | Disease | FDA | Therapeutics
Vertex announced U.S. FDA approval for TRIKAFTA in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
-
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. U.S. Food and Drug Administration (FDA announced it had approved Qalsody (tofersen) to…
-
Boehringer Ingelheim inaugurated largest European development centre for biotechnology
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Riss, Germany….
-
U.S. state-by-state analysis of COVID-19 impact revealed driving forces behind variations in health published in The Lancet
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
-
AI system generated novel proteins that meet structural design targets
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
-
Biotechnology | CRISPR | Diagnostics | Disease | Genomics | Therapeutics
Jennifer Doudna and Jill Banfield to lead $70 million initiative to edit the microbiome
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
-
U.S. FDA Approved First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for the Treatment of Cervical Dystonia
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
Parkinson’s disease biomarker found
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
-
U.S. spending $5 billion to speed up development of new COVID vaccines
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
-
Gene therapy allowed teen to see snowflakes for the first time
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institue announced that gene…
-
Defense Public Health celebrated opening of new $248 million public health laboratory
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
-
NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
-
Extremely rare gene variants point to a potential cause of age-related macular degeneration
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
-
Biotechnology | Diagnostics | Medicine | NIH | Oncology | Radiology | Therapeutics | Women's Health
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
Covid-19 pandemic and the expansion of the mortality gap between the U.S. and its European peers
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
-
U.S. FDA approved first Over-the-Counter Naloxone nasal spray
On Mar. 29, 2023, the U.S. Food and Drug Administration (FDA) announced approval of Narcan, 4 milligram naloxone…
-
CIRM invested $26 million in research
On Mar. 27, 2023, California Institute for Regenerative Medicine (CIRM) Board approved investing nearly $26 million in 17…
-
Hutchinson Cancer Center announced new “patient-centric” building in South Lake Union
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
-
Biology | CDC | Disease | Non-Profit Research | Therapeutics
CDC reported increasing threat of spread of antimicrobial-resistant fungus in healthcare facilities
On Mar. 20, 2023, the Centers for Disease Control and Prevention (CDC) reported that Candida auris (C. auris),…
-
Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
-
FDA Advisory Committee voted in support of favorable benefit-risk profile for Pfizer’s PAXLOVID
On Mar. 16, 2023, Pfizer announced that the U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee (AMDAC)…
-
Texas A&M scientists disable protective gene In mosquitoes
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: ‘RNA interference is essential to…
-
FDA authorized bivalent Pfizer-BioNTech COVID-19 vaccine as booster dose for certain children 6 months through 4 years of age
On Mar. 14, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
-
‘Deaths of Despair’ contributed to 17% rise in Minnesota’s death rate during COVID-19 pandemic
On Mar. 13, 2023, Mayo Clinic published a study that showed the COVID-19 pandemic was linked to a…
-
Pfizer announced acquisition of Seattle-based Seagen for $43 billion
On Mar. 13, 2023, Pfizer announced an agreement to acquire Seagen, a global biotechnology company that discovers, develops…
-
FDA approved first treatment for Rett syndrome
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…
-
Pfizer’s ZAVZPRET (zavegepant) Migraine Nasal Spray received FDA approval
On Mar. 10, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ZAVZPRET (zavegepant),…
